Press Release IFS reports industry leading results with 33% software revenue growth for 2023 Recurring Revenue up 35% YoY Cloud revenue up 46% YoY as new… CISION PRNewswireJanuary 30, 2024
Press Release OKG (1499.HK) Announces Title Sponsorship of HKDAS InnoFront 2024 Chairman Ren Yunan Appointed Industry Advisor and Final Judge HONG KONG, Jan. 30,… CISION PRNewswireJanuary 30, 2024
Press Release Diabolocom Applauded by Frost & Sullivan for Providing Excellent and Personalized Interactions to Improve the Customer Experience with Its AI Solution Diabolocom’s AI Solution increases staff productivity, controls pricing, and enhances the customer… CISION PRNewswireJanuary 30, 2024
Press Release Astana Opera Opens the World of Art to Children Astana Opera together with Eurasian Resources Group (ERG) presented the Children and… CISION PRNewswireJanuary 30, 2024
Press Release Tau Group Closes €11 Million Extension to Series-B Round to Fuel Growth and Enhance Production Capacity The round, led by CDP Venture Capital and Santander Alternative Investments (through… CISION PRNewswireJanuary 30, 2024
Press Release Yili Group Listed Among the 2023 Forbes China Globalization Innovators Selection Top 30 Brands SHANGHAI, Jan. 30, 2024 /PRNewswire/ — On January 26, 2024, the first… CISION PRNewswireJanuary 30, 2024
Press Release Results of the Phase III INSPIRE Study on Qilu Pharmaceutical's Iruplinalkib Published in the Journal of Thoracic Oncology JINAN, China, Jan. 30, 2024 /PRNewswire/ — The interim analysis results from… CISION PRNewswireJanuary 30, 2024
Press Release Tech DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD The nomination of novel Kv1.3 inhibitor DPT0218 for the treatment of various… CISION PRNewswireJanuary 30, 2024
